These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3131236)

  • 1. Interleukin 2 production in patients with Chagas' disease: correlation with anti-parasite antibody responses.
    Tarleton RL; de Andrade PP; de Andrade CR
    Immunol Lett; 1988 Mar; 17(3):229-34. PubMed ID: 3131236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic versus indeterminate infection.
    Cetron MS; Basilio FP; Moraes AP; Sousa AQ; Paes JN; Kahn SJ; Wener MH; Van Voorhis WC
    Am J Trop Med Hyg; 1993 Sep; 49(3):370-82. PubMed ID: 8372959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-12 enhances proliferation of peripheral blood mononuclear cells from Chagas' disease patients to Trypanosoma cruzi antigen.
    de Barros-Mazon S; Guariento ME; Abrahamsohn IA
    Immunol Lett; 1997 Jun; 57(1-3):39-45. PubMed ID: 9232423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two modes of idiotypic stimulation of T lymphocytes from patients with Chagas' disease: correlations with clinical forms of infection.
    Gazzinelli RT; Gazzinelli G; Cançado JR; Cardoso JE; Brener Z; Colley DG
    Res Immunol; 1990 Oct; 141(8):757-70. PubMed ID: 2128549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanosoma cruzi-induced suppression of IL-2 production. I. Evidence for the presence of IL-2-producing cells.
    Tarleton RL
    J Immunol; 1988 Apr; 140(8):2763-8. PubMed ID: 2965729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell mediated immunity in Chagas' disease. Trypanosoma cruzi antigens induce suppression of the in vitro proliferative response of mononuclear cells.
    Mosca W; Briceño L; Hernández MI
    Mem Inst Oswaldo Cruz; 1991; 86(2):147-52. PubMed ID: 1842408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine responses in Trypanosoma cruzi-infected children in Paraguay.
    Samudio M; Montenegro-James S; Cabral M; Martinez J; Rojas de Arias A; James MA
    Am J Trop Med Hyg; 1998 Jan; 58(1):119-21. PubMed ID: 9452302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell mediated immune response in patients with Chagas. Correlation with the presence of Chagasic cardiomyopathy.
    Mosca W; Briceño L
    Biol Res; 1993; 26(1-2):225-31. PubMed ID: 7670535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon- or interleukin-10 production is induced by related Trypanosoma cruzi antigens.
    Cuna WR; Encina JL; Cuna CR
    J Parasitol; 2000 Apr; 86(2):295-9. PubMed ID: 10780548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients.
    Pérez-Antón E; Egui A; Thomas MC; Puerta CJ; González JM; Cuéllar A; Segovia M; López MC
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006480. PubMed ID: 29750791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of parasite presence on the immunologic profile of peripheral blood mononuclear cells from chagasic patients after specific drug therapy.
    Dutra WO; da Luz ZM; Cançado JR; Pereira ME; Brigido-Nunes RM; Galvão LM; Colley DG; Brener Z; Gazzinelli G; Carvalho-Parra JF
    Parasite Immunol; 1996 Nov; 18(11):579-85. PubMed ID: 9226696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Trypanosoma cruzi antibody isotype profiles in patients with different clinical manifestations of Chagas' disease.
    Morgan J; Dias JC; Gontijo ED; Bahia-Oliveira L; Correa-Oliveira R; Colley DG; Powell MR
    Am J Trop Med Hyg; 1996 Oct; 55(4):355-9. PubMed ID: 8916788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral nitric oxide levels and antibody immune response of symptomatic and indeterminate Chagas' disease patients to commercial and autochthonous Trypanosoma cruzi antigen.
    Pérez-Fuentes R; Sánchez-Guillén MC; González-Alvarez C; Monteón VM; Reyes PA; Rosales-Encina JL
    Am J Trop Med Hyg; 1998 Jun; 58(6):715-20. PubMed ID: 9660451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of T-cell proliferation and interleukin 2 production in mice infected with Trypanosoma cruzi.
    Harel-Bellan A; Joskowicz M; Fradelizi D; Eisen H
    Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3466-9. PubMed ID: 6407015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of anti-R-13 antibodies in human Trypanosoma cruzi infection.
    Aznar C; Lopez-Bergami P; Brandariz S; Mariette C; Liegeard P; Alves MD; Barreiro EL; Carrasco R; Lafon S; Kaplan D
    FEMS Immunol Med Microbiol; 1995 Dec; 12(3-4):231-8. PubMed ID: 8745008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chagas' disease: Trypanosoma cruzi vs. the host immune system.
    Hontebeyrie-Joskowicz M; Minoprio P
    Res Immunol; 1991 Feb; 142(2):125-6. PubMed ID: 1907752
    [No Abstract]   [Full Text] [Related]  

  • 17. Restoration of in vitro immune responses of spleen cells from mice infected with Trypanosoma cruzi by supernatants containing interleukin 2.
    Tarleton RL; Kuhn RE
    J Immunol; 1984 Sep; 133(3):1570-5. PubMed ID: 6431001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiotypic/anti-idiotypic interactions in schistosomiasis and Chagas' disease.
    Gazzinelli RT; Parra JF; Correa-Oliveira R; Cançado JR; Rocha RS; Gazzinelli G; Colley DG
    Am J Trop Med Hyg; 1988 Sep; 39(3):288-94. PubMed ID: 3140682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunodominance: a new hypothesis to explain parasite escape and host/parasite equilibrium leading to the chronic phase of Chagas' disease?
    Rodrigues MM; Alencar BC; Claser C; Tzelepis F
    Braz J Med Biol Res; 2009 Mar; 42(3):220-3. PubMed ID: 19287899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of lymphoproliferative responses to Trypanosoma cruzi antigen in patients with the cardiac or indeterminate form of Chagas disease.
    de Barros-Mazon S; Guariento ME; da Silva CA; Coffman RL; Abrahamsohn IA
    Clin Immunol; 2004 Apr; 111(1):137-45. PubMed ID: 15093563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.